Vimarsana
Biggest News Aggregation in the World

Page 4 - Ericl Simpson News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ericl Simpson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ericl Simpson Today - Breaking & Trending Today

Safety data show Adbry well tolerated in treatment of moderate to severe atopic dermatitis - Vimarsana News

Safety data show Adbry well tolerated in treatment of moderate to severe atopic dermatitis

The results of pooled safety data for Adbry showed positive effects in the prolonged treatment of moderate to severe atopic dermatitis, according to a study. Adbry (tralokinumab, LEO Pharma) is the only FDA-approved biologic that specifically binds to and inhibits the interleukin (IL)-13 cytokine, one of the drivers of atopic dermatitis.

Source: healio.com
Make managing eczema easier | News, Sports, Jobs - Vimarsana News

Make managing eczema easier | News, Sports, Jobs

Jan 15, 2021 FAMILY FEATURES PHOTO Eczema is a common but annoying disease — in no small part due to its unpredictability. Family Features — More than 30 million Americans, including nearly 10 million children, have eczema, the umbrella term for a group of noncontagious, inflammatory and painful skin conditions marked by an itchy, rash-like appearance. Because one of the most challenging aspects of eczema can be its unpredictability, the National Eczema Association (NEA), designed an app to help people and parents easily track what’s important and make sense of it. The app, called E...